 | Up a level |
Johnson, Kimball A; Martin, Nancy; Nappi, Rossella E; Neal-Perry, Genevieve; Shapiro, Marla; Stute, Petra; Thurston, Rebecca C; Wolfman, Wendy; English, Marci; Franklin, Catherine; Lee, Misun; Santoro, Nanette (2023). Efficacy and Safety of Fezolinetant in Moderate-to-Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT. The Journal of clinical endocrinology and metabolism, 108(8), pp. 1981-1997. The Endocrine Society 10.1210/clinem/dgad058
Lensen, Sarah; Bell, Robin J; Carpenter, Janet S; Christmas, Monica; Davis, Susan R; Giblin, Karen; Goldstein, Steven R; Hillard, Tim; Hunter, Myra S; Iliodromiti, Stamatina; Jaisamrarn, Unnop; Khandelwal, Sunila; Kiesel, Ludwig; Kim, Bobae V; Lumsden, Mary Ann; Maki, Pauline M; Mitchell, Caroline M; Nappi, Rossella E; Niederberger, Craig; Panay, Nick; ... (2021). A core outcome set for genitourinary symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative. Menopause, 28(8), pp. 859-866. The North American menopause Society 10.1097/GME.0000000000001788
